These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 25444910)
1. Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma. Dogra S; Bandi S; Viswanathan P; Gupta S Cancer Lett; 2015 Jan; 356(2 Pt B):953-61. PubMed ID: 25444910 [TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response. Squarzanti DF; Sorrentino R; Landini MM; Chiesa A; Pinato S; Rocchio F; Mattii M; Penengo L; Azzimonti B Virol J; 2018 Nov; 15(1):176. PubMed ID: 30445982 [TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide inhibits cell proliferation and human papillomavirus oncogene expression in cervical cancer cells. Wang H; Gao P; Zheng J Biochem Biophys Res Commun; 2014 Sep; 451(4):556-61. PubMed ID: 25117446 [TBL] [Abstract][Full Text] [Related]
4. Molecular genetic characterization of p53 mutated oropharyngeal squamous cell carcinoma cells transformed with human papillomavirus E6 and E7 oncogenes. Oh JE; Kim JO; Shin JY; Zhang XH; Won HS; Chun SH; Jung CK; Park WS; Nam SW; Eun JW; Kang JH Int J Oncol; 2013 Aug; 43(2):383-93. PubMed ID: 23708675 [TBL] [Abstract][Full Text] [Related]
5. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer. Munagala R; Aqil F; Jeyabalan J; Gupta RC Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375 [TBL] [Abstract][Full Text] [Related]
6. HPV-inactive cell populations arise from HPV16-transformed human keratinocytes after p53 knockout. Abboodi F; Buckhaults P; Altomare D; Liu C; Hosseinipour M; Banister CE; Creek KE; Pirisi L Virology; 2021 Feb; 554():9-16. PubMed ID: 33321328 [TBL] [Abstract][Full Text] [Related]
7. HPV-16 E6 and E7 oncogene expression is downregulated as a result of Mdm2 knockdown. Diaz D; Santander MA; Chavez JA Int J Oncol; 2012 Jul; 41(1):141-6. PubMed ID: 22504553 [TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation. Liu Y; McKalip A; Herman B J Cell Biochem; 2000 May; 78(2):334-49. PubMed ID: 10842327 [TBL] [Abstract][Full Text] [Related]
9. Functional interaction between human papillomavirus type 16 E6 and E7 oncoproteins and cigarette smoke components in lung epithelial cells. Muñoz JP; González C; Parra B; Corvalán AH; Tornesello ML; Eizuru Y; Aguayo F PLoS One; 2012; 7(5):e38178. PubMed ID: 22662279 [TBL] [Abstract][Full Text] [Related]
10. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3. Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046 [TBL] [Abstract][Full Text] [Related]
11. Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7. Maher DM; Bell MC; O'Donnell EA; Gupta BK; Jaggi M; Chauhan SC Mol Carcinog; 2011 Jan; 50(1):47-57. PubMed ID: 21061268 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of human papillomavirus E6/E7 oncogene by arsenic trioxide in cervical carcinoma cells. Um SJ; Lee SY; Kim EJ; Myoung J; Namkoong SE; Park JS Cancer Lett; 2002 Jul; 181(1):11-22. PubMed ID: 12430174 [TBL] [Abstract][Full Text] [Related]
13. Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis. Masterson L; Winder DM; Ball SL; Vaughan K; Lehmann M; Scholtz LU; Sterling JC; Sudhoff HH; Goon PK BMC Cancer; 2016 Jun; 16():367. PubMed ID: 27296171 [TBL] [Abstract][Full Text] [Related]
14. Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2. Tung MC; Lin PL; Cheng YW; Wu DW; Yeh SD; Chen CY; Lee H Oncotarget; 2016 May; 7(22):32362-74. PubMed ID: 27083050 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes. Zhou J; Li B; Peng C; Wang F; Fu Z; Zhou C; Hong D; Ye F; Lü W; Xie X Antiviral Res; 2013 May; 98(2):305-13. PubMed ID: 23523766 [TBL] [Abstract][Full Text] [Related]
16. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter. Hirao N; Iwata T; Tanaka K; Nishio H; Nakamura M; Morisada T; Morii K; Maruyama N; Katoh Y; Yaguchi T; Ohta S; Kukimoto I; Aoki D; Kawakami Y Gynecol Oncol; 2019 Nov; 155(2):340-348. PubMed ID: 31477279 [TBL] [Abstract][Full Text] [Related]
17. Tobacco smoke activates human papillomavirus 16 p97 promoter and cooperates with high-risk E6/E7 for oxidative DNA damage in lung cells. Peña N; Carrillo D; Muñoz JP; Chnaiderman J; Urzúa U; León O; Tornesello ML; Corvalán AH; Soto-Rifo R; Aguayo F PLoS One; 2015; 10(4):e0123029. PubMed ID: 25830243 [TBL] [Abstract][Full Text] [Related]
18. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line. Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640 [TBL] [Abstract][Full Text] [Related]
19. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53. Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502 [TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide induces cervical cancer apoptosis, but specifically targets human papillomavirus-infected cell populations. Wen X; Li D; Zhang Y; Liu S; Ghali L; Iles RK Anticancer Drugs; 2012 Mar; 23(3):280-7. PubMed ID: 22245994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]